VaxThera considers future partners for clinical trials

VaxThera considers future partners for clinical trials

Equity Healthcare Pharmaceuticals Coronavirus Colombia Andean

Colombian vaccination company VaxThera could look for partners to help fund clinical trials next year, building on an initial $54 million investment from local financial services firm Grupo Sura, founder and CEO Jorge Osorio said in an interview with LatinFinance. "We have support for the first phase, but we are looking for support for additional phases," Osorio said. With the money from Sura, VaxThera plans to build a production facility either on the outskirts of Bogotá or Medellín with the ai

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial